- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/02 - Hepadnaviridae, e.g. hepatitis B virus
Patent holdings for IPC class C07K 14/02
Total number of patents in this class: 233
10-year publication summary
|
11
|
15
|
29
|
13
|
19
|
9
|
10
|
5
|
5
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GlobeImmune, Inc. | 73 |
11 |
| Xiamen University | 567 |
7 |
| Yang Sheng Tang Company Limited | 55 |
6 |
| Precigen Inc | 107 |
5 |
| The Trustees of the University of Pennsylvania | 4400 |
4 |
| Auckland UniServices Limited | 499 |
4 |
| F. Hoffmann-La Roche AG | 7847 |
3 |
| The Board of Trustees of the Leland Stanford Junior University | 6609 |
3 |
| The Trustees of Columbia University in the City of New York | 3636 |
3 |
| Beacle Inc. | 6 |
3 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3149 |
3 |
| Institut Pasteur | 787 |
3 |
| ISA Pharmaceuticals B.V. | 32 |
3 |
| National University Corporation Ehime University | 126 |
3 |
| Ruprecht-Karls-Universität Heidelberg | 245 |
3 |
| Universitat Heidelberg | 277 |
3 |
| Shanghai HEP Pharmaceutical Co., Ltd. | 15 |
3 |
| Emergex Vaccines Holding Limited | 26 |
3 |
| The Regents of the University of California | 20594 |
2 |
| Advanced Life Science Institute, Inc. | 23 |
2 |
| Other owners | 156 |